Clinical Trial Details
| Trial ID: | L5647 |
| Source ID: | NCT01465152 |
| Associated Drug: | Metformin |
| Title: | Comparison of Metformin, Repaglinide or the Combination of Both in Subjects With Type 2 Diabetes |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes|Diabetes Mellitus, Type 2 |
| Interventions: | DRUG: metformin|DRUG: repaglinide |
| Outcome Measures: | Primary: Change of % HbA1c (glycosylated haemoglobin) in blood | Secondary: Change of the mean body mass index calculated as weight in kilograms divided by the square of height in metres|Incidence of clinical and/or biochemistry hypoglycaemia episodes|Incidence of adverse events|Presence of laboratory abnormalities in routine blood analyses|Change of the blood pressure and/or heart rate|Treatment compliance |
| Sponsor/Collaborators: | Sponsor: Novo Nordisk A/S |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE4 |
| Enrollment: | 182 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2002-03-06 |
| Completion Date: | 2004-10-21 |
| Results First Posted: | |
| Last Update Posted: | 2017-02-20 |
| Locations: | Novo Nordisk Investigational Site, Barcelona, 08020, Spain|Novo Nordisk Investigational Site, Benamargosa, 29718, Spain|Novo Nordisk Investigational Site, Burlada, 31600, Spain|Novo Nordisk Investigational Site, Camas, 41900, Spain|Novo Nordisk Investigational Site, Fuenlabrada, 28942, Spain|Novo Nordisk Investigational Site, Gijón, 33212, Spain|Novo Nordisk Investigational Site, Granada, 18012, Spain|Novo Nordisk Investigational Site, Lugo, 27004, Spain|Novo Nordisk Investigational Site, Madrid, 28021, Spain|Novo Nordisk Investigational Site, Madrid, 28030, Spain|Novo Nordisk Investigational Site, Madrid, 28035, Spain|Novo Nordisk Investigational Site, Portugalete, 48920, Spain|Novo Nordisk Investigational Site, San Adria del Besos, 08930, Spain|Novo Nordisk Investigational Site, Santander, 39009, Spain|Novo Nordisk Investigational Site, Santander, 39011, Spain|Novo Nordisk Investigational Site, Tegueste, 38280, Spain|Novo Nordisk Investigational Site, Valencia, 46021, Spain|Novo Nordisk Investigational Site, Zaragoza, 50007, Spain |
| URL: | https://clinicaltrials.gov/show/NCT01465152 |
